- Home
- RBOT vs TRIB Comparison
RBOT vs TRIB Comparison
Compare RBOT & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- TRIB
- Stock Information
- Founded
- RBOT 2014
- TRIB 1992
- Country
- RBOT United States
- TRIB Ireland
- Employees
- RBOT N/A
- TRIB N/A
- Industry
- RBOT Medical Specialities
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RBOT Health Care
- TRIB Health Care
- Exchange
- RBOT Nasdaq
- TRIB Nasdaq
- Market Cap
- RBOT 17.0M
- TRIB 18.3M
- IPO Year
- RBOT N/A
- TRIB N/A
- Fundamental
- Price
- RBOT $2.72
- TRIB $0.95
- Analyst Decision
- RBOT Hold
- TRIB
- Analyst Count
- RBOT 1
- TRIB 0
- Target Price
- RBOT $7.00
- TRIB N/A
- AVG Volume (30 Days)
- RBOT 82.0K
- TRIB 67.0K
- Earning Date
- RBOT 11-12-2025
- TRIB 11-14-2025
- Dividend Yield
- RBOT N/A
- TRIB N/A
- EPS Growth
- RBOT N/A
- TRIB N/A
- EPS
- RBOT N/A
- TRIB N/A
- Revenue
- RBOT N/A
- TRIB $61,555,000.00
- Revenue This Year
- RBOT N/A
- TRIB $13.51
- Revenue Next Year
- RBOT N/A
- TRIB $13.14
- P/E Ratio
- RBOT N/A
- TRIB N/A
- Revenue Growth
- RBOT N/A
- TRIB 8.31
- 52 Week Low
- RBOT $2.44
- TRIB $0.48
- 52 Week High
- RBOT $19.00
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- RBOT 29.83
- TRIB 56.27
- Support Level
- RBOT $2.48
- TRIB $0.80
- Resistance Level
- RBOT $3.18
- TRIB $0.94
- Average True Range (ATR)
- RBOT 0.42
- TRIB 0.08
- MACD
- RBOT -0.07
- TRIB 0.01
- Stochastic Oscillator
- RBOT 12.05
- TRIB 72.73
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.